Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Alarcon

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Pediatric Research|February 23, 2022
Cerebral near-infrared spectroscopy monitoring (NIRS) in children and adults: a systematic review with meta-analysisMathias Lühr Hansen, Simon Hyttel-Sørensen, Janus Christian Jakobsen, et al.
Bone Marrow Transplantation|January 31, 2023
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantationMiriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, et al.
Bone Marrow Transplantation|July 13, 2021
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplantAna Alarcon Tomas, Karissa Whiting, Molly Maloy, et al.
Jornal De Pediatria|October 21, 2020
Prevalence and diagnostic accuracy of microcephaly in a pediatric cohort in Brazil: a retrospective cross-sectional studyAna Paula Antunes Pascalicchio Bertozzi, Rosa Estela Gazeta, Thamirys Cosmo Gillo Fajardo, et al.
Blood Advances|November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapyKitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
The Lancet Regional Health. Europe|April 9, 2024
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
The Lancet Regional Health. Europe|July 25, 2024
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892]Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Blood Advances|December 12, 2022
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndromeShakthi T Bhaskar, Vivek G Patel, David L Porter, et al.
Nature Medicine|July 3, 2023
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim resultsJae H Park, Karthik Nath, Sean M Devlin, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Pediatric Research|February 23, 2022
Cerebral near-infrared spectroscopy monitoring (NIRS) in children and adults: a systematic review with meta-analysisMathias Lühr Hansen, Simon Hyttel-Sørensen, Janus Christian Jakobsen, et al.
Bone Marrow Transplantation|January 31, 2023
EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantationMiriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, et al.
Bone Marrow Transplantation|July 13, 2021
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplantAna Alarcon Tomas, Karissa Whiting, Molly Maloy, et al.
Jornal De Pediatria|October 21, 2020
Prevalence and diagnostic accuracy of microcephaly in a pediatric cohort in Brazil: a retrospective cross-sectional studyAna Paula Antunes Pascalicchio Bertozzi, Rosa Estela Gazeta, Thamirys Cosmo Gillo Fajardo, et al.
Blood Advances|November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapyKitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
The Lancet Regional Health. Europe|April 9, 2024
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
The Lancet Regional Health. Europe|July 25, 2024
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892]Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Blood Advances|December 12, 2022
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndromeShakthi T Bhaskar, Vivek G Patel, David L Porter, et al.
Nature Medicine|July 3, 2023
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim resultsJae H Park, Karthik Nath, Sean M Devlin, et al.
Pageof 6